Abiraterone and increased survival in metastatic prostate cancer

…, S North, L Chu, KN Chi, RJ Jones…

Index: O'Hagan; White; Jones Journal of Labelled Compounds and Radiopharmaceuticals, 1994 , vol. 34, # 9 p. 871 - 880

Full Text: HTML

Citation Number: 2224

Abstract

Background Biosynthesis of extragonadal androgen may contribute to the progression of castration-resistant prostate cancer. We evaluated whether abiraterone acetate, an inhibitor of androgen biosynthesis, prolongs overall survival among patients with metastatic

 Related Synthetic Route
1-Bromo-3-chloro-2-propanone Structure

53535-68-5

1-Bromo-3-chlor...

~74%

1-bromo-3-chloropropan-2-ol Structure

4540-44-7

1-bromo-3-chlor...

[3-2H2]-3-chloro-2-hydroxypropyl-p-toluenesulfonate Structure

83385-52-8

[3-2H2]-3-chlor...

~71%

epichlorohydrin-1,1-d2 Structure

83385-55-1

epichlorohydrin...

1,3-Dichloroacetone Structure

534-07-6

1,3-Dichloroacetone

~78%

1,3-Dichloro-2-propanol Structure

96-23-1

1,3-Dichloro-2-...

Propanal,3-bromo-2-oxo-,one Structure

39755-31-2

Propanal,3-brom...

~%

1-Bromo-3-chloro-2-propanone Structure

53535-68-5

1-Bromo-3-chlor...

acetic acid Structure

64-19-7

acetic acid

~%

Chloroacetyl chloride Structure

79-04-9

Chloroacetyl ch...


Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved